| pubmed-article:1452369 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1452369 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1452369 | lifeskim:mentions | umls-concept:C0021308 | lld:lifeskim |
| pubmed-article:1452369 | lifeskim:mentions | umls-concept:C0236396 | lld:lifeskim |
| pubmed-article:1452369 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
| pubmed-article:1452369 | lifeskim:mentions | umls-concept:C0456389 | lld:lifeskim |
| pubmed-article:1452369 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:1452369 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1452369 | pubmed:dateCreated | 1993-1-6 | lld:pubmed |
| pubmed-article:1452369 | pubmed:abstractText | We have investigated prospectively the serum cortisol response to acute myocardial infarction in 70 consecutive patients admitted to a coronary care unit and we have shown that the levels are significantly raised early in the course of the illness and prior to elevation of the cardiac specific enzyme fraction, creatine kinase MB. The magnitude of the cortisol response is related to the size of the ensuing infarction (rs = 0.54) as calculated from the total creatine kinase MB release (P < 0.001) and very high levels (> 2000 mumol/l) are predictive of mortality (P < 0.05). Serum cortisol levels may have a role in the early identification of myocardial infarction and in predicting those patients with a poor prognosis. | lld:pubmed |
| pubmed-article:1452369 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1452369 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1452369 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1452369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1452369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1452369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1452369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1452369 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1452369 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:1452369 | pubmed:issn | 0167-5273 | lld:pubmed |
| pubmed-article:1452369 | pubmed:author | pubmed-author:MurrayR GRG | lld:pubmed |
| pubmed-article:1452369 | pubmed:author | pubmed-author:LittlerW AWA | lld:pubmed |
| pubmed-article:1452369 | pubmed:author | pubmed-author:FoxJ PJP | lld:pubmed |
| pubmed-article:1452369 | pubmed:author | pubmed-author:DaviesM KMK | lld:pubmed |
| pubmed-article:1452369 | pubmed:author | pubmed-author:JaggerJJ | lld:pubmed |
| pubmed-article:1452369 | pubmed:author | pubmed-author:BainR JRJ | lld:pubmed |
| pubmed-article:1452369 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1452369 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:1452369 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1452369 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1452369 | pubmed:pagination | 145-50 | lld:pubmed |
| pubmed-article:1452369 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:meshHeading | pubmed-meshheading:1452369-... | lld:pubmed |
| pubmed-article:1452369 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1452369 | pubmed:articleTitle | Serum cortisol levels predict infarct size and patient mortality. | lld:pubmed |
| pubmed-article:1452369 | pubmed:affiliation | Department of Cardiovascular Medicine, East Birmingham Hospital, UK. | lld:pubmed |
| pubmed-article:1452369 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1452369 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1452369 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
